KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Change in Accured Expenses (2016 - 2026)

National Health Investors filings provide 18 years of Change in Accured Expenses readings, the most recent being -$7.1 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 16.91% to -$7.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 million, a 203.19% increase, with the full-year FY2025 number at $5.5 million, up 67.12% from a year prior.
  • Change in Accured Expenses hit -$7.1 million in Q1 2026 for National Health Investors, down from $8.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.1 million in Q4 2025 to a low of -$8.5 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $1.8 million (2025), compared with a mean of $473411.8.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 366.12% in 2022 and later crashed 508.13% in 2024.
  • National Health Investors' Change in Accured Expenses stood at $3.0 million in 2022, then surged by 54.77% to $4.6 million in 2023, then soared by 46.75% to $6.8 million in 2024, then rose by 19.34% to $8.1 million in 2025, then plummeted by 187.67% to -$7.1 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$7.1 million (Q1 2026), $8.1 million (Q4 2025), and $1.8 million (Q3 2025) per Business Quant data.